Alprostadil Cream treatment for female sexual arousal disorder to be presented.
Publication: Biotech Week
Publication Date: 22-SEP-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 SEP 22 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it will present the new findings of a pilot clinical study conducted offshore, entitled "A Pilot Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD)."
The presentation will take place...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
